Last quarter (Q3 2024), Cardiol Therapeutics's total revenue was $―, a decrease of ― from the same quarter last year. In Q3, Cardiol Therapeutics's net income was $-12.73M. See Cardiol Therapeutics’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Total Revenue	$ ―	$ ―	$ ―	$ 78.76K	$ ―	$ ―
Cost of Revenue	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Gross Profit	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Operating Expense	$ 38.32M	$ 29.79M	$ 41.34M	$ 38.74M	$ 20.69M	$ 14.13M
Operating Income	$ -38.32M	$ -29.79M	$ -41.34M	$ -38.66M	$ -20.69M	$ -14.13M
Net Non Operating Interest Income Expense	$ 1.33M	$ 2.04M	$ 1.24M	$ -106.00K	$ -76.58K	$ -244.80K
Other Income Expense	$ -834.41K	$ -331.46K	$ -6.41M	$ 6.92M	$ -27.06K	$ 198.94K
Pretax Income	$ -36.14M	$ -28.13M	$ -36.45M	$ -31.64M	$ -20.64M	$ -13.68M
Tax Provision	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Earnings From Equity Interest Net Of Tax	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Net Income Common Stockholders	$ -36.14M	$ -28.13M	$ -36.45M	$ -31.64M	$ -20.64M	$ -13.68M
Basic EPS	$ -0.54	$ -0.44	$ -0.49	$ -0.73	$ -0.69	$ -0.53
Diluted EPS	$ -0.54	$ -0.44	$ -0.49	$ -0.73	$ -0.69	$ -0.53
Basic Average Shares	$ 271.02M	$ 64.46M	$ 62.51M	$ 43.22M	$ 29.86M	$ 25.82M
Diluted Average Shares	$ 271.02M	$ 64.46M	$ 62.51M	$ 43.22M	$ 29.86M	$ 25.82M
Dividend Per Share	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Total Operating Income As Reported	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Basic E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Diluted E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Rent Expense Supplemental	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Total Expenses	$ 38.32M	$ 29.79M	$ ―	$ -38.74M	$ -20.69M	$ -14.13M
Net Income From Continuing And Discontinued Operation	$ -36.14M	$ -28.13M	$ -36.45M	$ -31.64M	$ -20.64M	$ -13.68M
Normalized Income	$ -33.83M	$ -20.67M	$ -26.79M	$ -23.25M	$ -15.17M	$ -10.06M
Interest Expense	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
EBIT	$ -36.14M	$ -28.13M	$ -36.45M	$ -31.64M	$ -20.64M	$ -13.68M
EBITDA	$ -35.74M	$ -27.88M	$ -36.23M	$ -38.44M	$ -20.46M	$ -13.53M

Currency in USD

Cardiol Therapeutics Earnings and Revenue History

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing